About Envigo
Envigo is a Healthcare company based in Huntingdon (United Kingdom) founded in 2015, and was acquired by Inotiv in November 2021. Drug discovery and development services are provided using research models. The company has 2 employees. Envigo offers products and services including Toxicology Services, Histology Services, Research Models, and DMPK Services. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its legal entity in India is Envigo Research Private Limited (U73100GJ2013FTC074361).
Company details
Provider of drug discovery and development services using research models. It offers a full spectrum of services, from discovery and translational sciences to safety assessment and toxicology. These services encompass disease pharmacology (in vitro and in vivo), drug metabolism and pharmacokinetics (DMPK), bioanalysis, and cell and molecular biology. The company also provides research models and related services, including genetically engineered models, contract breeding, and surgical services. Support services include specialized histology and pathology, chemical services, and diet and bedding for research animals. Consulting services are available in areas such as DMPK data analysis and biomarker analysis.
- Headquarters Huntingdon, United Kingdom
- Employees 2
- Stage Acquired
- SectorsHealthcare
- Website envigo.com
- Social LinkedIn
- Acquired by Inotiv (Nov 2021)
- Legal Name Envigo Research Private Limited
- Date of Incorporation 05 Apr, 2013
- Jurisdiction Ahmedabad, Gujarat, India
- Indian entity revenue₹47,000
FY 2022 · +571% YoY
- Indian entity net profit₹6.09 Cr
FY 2022 · 129505% margin
- Indian entity EBITDA₹6.09 Cr
FY 2022 · 129505% margin
- Latest Funding Round$1.71M (USD), Grant
Jan 2016
- InvestorsEuropean Union
& 2 more
- Employee Count2
- Acquired by
Associated legal entities of Envigo
Envigo operates through Envigo Research Private Limited (under liquidation). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Envigo Research Private Limited CIN U73100GJ2013FTC074361 | Under Liquidation | 05 Apr 2013 | Ahmedabad, Gujarat | ₹0.0 Cr | 2 | 3 | View details |
Products & Services of Envigo
Envigo offers a comprehensive portfolio of products and services, including Toxicology Services, Histology Services, Research Models, and DMPK Services.
Conducts studies to evaluate drug and chemical safety risks.
Processes tissues for analysis in nonclinical development.
Supplies genetically engineered models for scientific studies.
Analyzes drug metabolism and pharmacokinetics in vivo.
Funding Insights of Envigo
- Total Rounds 1
- Last Round Grant — $1.71M
- First Round $1.71M
(Jan 2016)
- Investors Count 1
All 1 funding rounds of Envigo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2016 | $1.71M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Envigo
Envigo has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Union, Inotiv Co and AnaPath.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Clinical development and regulatory services are provided by Inotiv. | 1974 | inotivco.com | Lafayette, United States | |
Specializes in histopathology, toxicology, and molecular pathology services for clients. | 2005 | anapath.ch | Liestal, Switzerland |
Investor details for Envigo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Envigo Research Private Limited (Envigo)
Envigo Research Private Limited is the primary company behind Envigo. The board of Envigo Research Private Limited currently have 3 directors; the longest-serving is Michael Gregory O'reilly, appointed in 2014. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Michael Gregory O'reilly DIN 06997800 | Director | 12 Dec 2014 | 11 yrs 10 mo | Envigo Research Private Limited |
| Hemendra Ishverlal Nagori DIN 08378978 | Director | 14 Feb 2019 | 7 yrs 8 mo | Envigo Research Private Limited |
| Umesh Harjivandas Ved DIN 00003393 | IRP/RP/Liquidator | 21 Apr 2023 | 3 yrs 6 mo | Envigo Research Private Limited |
People of Envigo
138 people are tracked at Envigo (70 in leadership, 6 in board & advisors, 62 in team); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Johnathan Furr | Director Developmental And Reproductive Toxicology | Leadership |
Robert Leasure Jr. | CEO | Leadership |
Beth A. Taylor | SVP, Finance & CFO | Leadership |
Lizanne Muller | Group President, RMS | Leadership |
Mike Garrett | Chief Commercial Officer | Leadership |
Jaymie Voorhees | Study Director II | Leadership |
Chris Null | Study Director | Leadership |
Glenn Washer | Group President, Safety Assessment | Leadership |
Greg Beattie | COO, DSA | Leadership |
John Sagartz | Chief Strategy Officer | Leadership |
Brennan Freeman | Vice President - Finance & Corporate Controller | Leadership |
James Norman | Vice President Of Business Development - Discovery & Translational Sciences | Leadership |
Diane Brecha | Senior Director Business Development | Leadership |
Bryan Lee | US Government Sales Director | Leadership |
Jason Werner | Director, Quality Management Systems | Leadership |
Travis Rothrock | Director, Portfolio Marketing | Leadership |
Cole Mietzner | Vice President - Information Security And Infrastructure | Leadership |
Seth H. | Associate Director Business Development | Leadership |
Nicole McDaniel | Director, Corporate Accounting & External Reporting | Leadership |
Chris Coffman | Senior Director Financial Planning Analysis | Leadership |
118 more people are available in the full profile.
Complete people profiles for Envigo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Envigo
Figures of Envigo Research Private Limited, the primary company behind Envigo, for FY 2022. Revenue was ₹47,000 (+571% year on year). Net profit was ₹6.09 Cr (129505% margin). EBITDA was ₹6.09 Cr (129505% margin). Revenue has grown at a compounded annual rate of -85% over three years and -77% over five years.
- ₹47,000Revenue · FY 2022 · +571% YoY
- ₹6.09 CrNet profit · 129505% margin
- ₹6.09 CrEBITDA · 129505% margin
- ₹17.73 CrPaid-up capital
- 2Employees (provident fund records)
- -85%Revenue CAGR, 3 years
- -77%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Envigo Research Private Limited are on its company page.
Detailed financial statements for Envigo
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Envigo
The website of Envigo (envigo.com) receives about 5.8K visits a month.
- Monthly visits5.8K
▼ 9.3% vs previous month
Websites whose visitors overlap most with Envigo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| inotiv.com | 100% | 51.7K | #663,656 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Envigo
Complete news archive for Envigo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Envigo
Envigo was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Envigo is headquartered in Huntingdon, United Kingdom.
Envigo has 2 employees.
The primary company behind Envigo, Envigo Research Private Limited, reported revenue of ₹47,000 for FY 2022, up 571% year on year.
Provider of drug discovery and development services using research models. It offers a full spectrum of services, from discovery and translational sciences to safety assessment and toxicology. These services encompass disease pharmacology (in vitro and in vivo), drug metabolism and pharmacokinetics (DMPK), bioanalysis, and cell and molecular biology. The company also provides research models and related services, including genetically engineered models, contract breeding, and surgical services. Support services include specialized histology and pathology, chemical services, and diet and bedding for research animals. Consulting services are available in areas such as DMPK data analysis and biomarker analysis.
Envigo offers Toxicology Services, Histology Services, Research Models, and DMPK Services.
Envigo has 3 investors. Key investors include European Union, Inotiv Co, and AnaPath.
Envigo operates through Envigo Research Private Limited.
Yes. Envigo was acquired by Inotiv in November 2021.
The legal entities of Envigo currently have 3 directors, including Hemendra Ishverlal Nagori, Umesh Harjivandas Ved, Michael Gregory O'reilly.